David A. Brcka, M.D., an orthopedic surgeon specializing in sports medicine, has joined OrthoAtlanta. Dr. Brcka, who has advanced training in arthroscopic hip preservation, was formerly a partner and attending physician at the Sports Medicine Institute in Clermont, Florida.
David A. Brcka, M.D., Joins OrthoAtlanta

“Dr. Brcka joins the OrthoAtlanta orthopedic sports medicine group in Newnan and Fayetteville to serve patients with many types of hip, knee and shoulder disorders,” stated Michael Behr, M.D., OrthoAtlanta Medical Director, in the February 1, 2017 news release. “While completing his fellowship, Dr. Brcka trained under the direction of Christopher Larson, M.D., a widely recognized pioneer in hip arthroscopy. Today, Dr. Brcka brings this expertise to OrthoAtlanta to provide arthroscopic hip preservation surgery, and other arthroscopic treatments, to our patients.”
According to the news release, “Dr. David Brcka graduated from Iowa State University, in Ames, Iowa, with a Bachelor of Science degree in Biology. As an undergraduate student at ISU, Dr. Brcka was a member of the Iowa State University football team, and was elected as the first sophomore co-captain in the team’s 100-year history. His love of football and sports led him to his interest in sports medicine and treating sports injuries. Dr. Brcka received his Doctor of Medicine degree at the University of Iowa Carver College of Medicine in Iowa City, Iowa. He completed his Orthopaedic Surgery Residency at Orlando Regional Healthcare in Orlando, Florida, followed by sports medicine fellowship training at Minnesota Orthopedic Sports Medicine Institute in Eden Prairie, Minnesota.
As for his plans, Dr. Brcka told OTW, “I will start out by introducing myself to the local community (patients, local businesses, and primary care physicians), building a solid referral base, and educating referring partners and the community about femoroacetabular impingement and the benefits of arthroscopic treatment. In addition, I will soon get involved with local sports teams.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.